Gyre Therapeutics, Inc. GYRE Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s invested capital?
- Gyre Therapeutics, Inc. (GYRE) reported invested capital of $64.63M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s invested capital changed year-over-year?
- Gyre Therapeutics, Inc.'s invested capital increased by 18.2% year-over-year, from $54.66M to $64.63M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s invested capital has grown at a 8.1% compound annual growth rate (CAGR), from $47.35M to $69.9M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).